Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Ethiopia has been increasing in recent years due to various factors.
Customer preferences: Customers in Ethiopia have been increasingly aware of the importance of vaccines in preventing diseases. This has led to a higher demand for vaccines, especially among parents who want to protect their children from preventable diseases. Additionally, the government has been promoting vaccination campaigns to increase the awareness of the benefits of vaccines.
Trends in the market: The vaccines market in Ethiopia has been growing steadily in recent years. This growth can be attributed to the increasing demand for vaccines, as well as the expansion of the healthcare sector in the country. Ethiopia has been investing heavily in its healthcare infrastructure, which has led to an increase in the availability of vaccines in the country. Furthermore, the government has been working to improve the distribution network for vaccines, which has made it easier for people to access vaccines.
Local special circumstances: One of the main challenges in the vaccines market in Ethiopia is the lack of infrastructure in some parts of the country. This has made it difficult to distribute vaccines to remote areas, which has led to a lower vaccination rate in these regions. Additionally, there is a lack of awareness about the importance of vaccines in some communities, which has led to a lower demand for vaccines in these areas.
Underlying macroeconomic factors: The Ethiopian economy has been growing in recent years, which has led to an increase in the demand for healthcare services. This has created an opportunity for the vaccines market to grow, as more people are able to afford healthcare services. Furthermore, the government has been investing heavily in the healthcare sector, which has led to an increase in the availability of vaccines in the country. However, there are still challenges that need to be addressed, such as improving the distribution network for vaccines and increasing awareness about the importance of vaccines in some communities.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
